Larisa V. Suturina

Professor Larisa Suturina, MD, PhD, Ob&Gyn is a Chief researcher and Head of the Department of Reproductive Health Protection, Scientific Center for Family Health and Human Reproduction Problems, Irkutsk, Russia.

Scientific interests: endocrine disorders, infertility, PCOS, endometrium, endometriosis, uterine fibroids, oxidative stress, gut microbiome.

Professor Suturina served as a PI in a population-based study "PCOS prevalence and phenotype in Eastern Siberia (ESPEP)", and, currently, participates in the “International Multicenter Consortium to define the features of PCOS, including hirsutism”. She was also a principal investigator in 12 clinical phases 2-4 trials on different topics (uterine fibroids, contraception, CIN, AMB, endometriosis, benign breast disease, endometrial hyperplasia).

Research support (last years)

• 2023 to present time - Head of the project "Prediction of metabolic and psycho-emotional disorders in women of different age groups with hyperandrogenic disorders to develop personalized approaches to prevention and treatment" (#1022040800022-7-3.2.2;3.2.24),
• 2020-2022 – Head of the initiative project "Early detection and prevention of metabolic syndrome associated with hyperandrogenism and estrogen deficiency in women of reproductive and postmenopausal age", with the support of the Ministry of Science and Education of the Russian Federation (#АААА-А20-120120790036-3)
• 2017-2019 – Head of the initiative project "Early detection and correction of neuro-endocrine-metabolic and psychoemotional manifestations of reproductive disorders associated with hyperandrogenism", with the support of the Ministry of Science and Education of the Russian Federation(#АААА-А18-118011990043-5)
• 2018-2019 – Head of the project «Stigma and discrimination of Siberian people living with HIV(PLHIV) by Ob&Gyn specialists and discrimination-reduction programming, with the support of The European Society of Contraception and Reproductive Health (grant P-2017-B-03)
• 2011 – Head of the project “The technology of early diagnostics of infertility”, supported by Irkutsk Region Government, Professor Larisa V. Suturina is a scientific supervisor of 30 Ph.D. students. She is an author of a chapter “The Epidemiology of Polycystic Ovary Syndrome” in the book “Polycystic Ovary Syndrome” (Cambridge University Press, 2022) and other books. She has published more than 300 papers in scientific journals and has served as a co-author of the Russian National Clinical guidelines on PCOS and other gynecological diseases.
• International professional societies: International Society of Gynecological Endocrinology (ISGE) (member, since 2004), Androgen Excess&PCOS Society (member, since 2014), and Endocrine Society (member, since 2014).

ORCID 0000-0002-6271-7803

Selected publications

1. Bitzer J, Bouchard C, Zatik J, Weyers S, Piltonen T, Suturina L, et al. Effects of E4/DRSP on self-reported physical and emotional premenstrual and menstrual symptoms: data from the phase 3 clinical trial in Europe and Russia. Eur J Contracept Reprod Health Care. 2024 Jun 21:1-10. doi: 10.1080/13625187.2024.2359117. Epub ahead of print. PMID: 38904165.
2. Suturina L, Lizneva D, Lazareva L, et al. Ethnicity and the Prevalence of Polycystic Ovary Syndrome: The Eastern Siberia PCOS Epidemiology and Phenotype Study. J Clin Endocrinol Metab. 2024 Jun 18:dgae424. doi: 10.1210/clinem/dgae424. Epub ahead of print. PMID: 38888252.
3. Lazareva L, Suturina L, Atalyan A, et al. Ovarian Morphology in Non-Hirsute, Normo-Androgenic, Eumenorrheic Premenopausal Women from a Multi-Ethnic Unselected Siberian Population. Diagnostics (Basel). 2024 Mar 22;14(7):673. doi: 10.3390/diagnostics14070673. PMID: 38611586; PMCID: PMC11012196.
4. Suturina L, Belkova N, Igumnov I, et al. Polycystic Ovary Syndrome and Gut Microbiota: Phenotype Matters. Life (Basel). 2022 Dec 20;13(1):7. doi: 10.3390/life13010007. PMID: 36675956; PMCID: PMC9861125.
5. Suturina L, Lizneva D, Atalyan A, et al. Establishing Normative Values to Determine the Prevalence of Biochemical Hyperandrogenism in Premenopausal Women of Different Ethnicities from Eastern Siberia. Diagnostics (Basel). 2022 Dec 22;13(1):33. doi: 10.3390/diagnostics13010033. PMID: 36611327; PMCID: PMC9818891.
6. Chen MJ, Jensen JT, Kaunitz AM, Achilles SL, Zatik J, Weyers S, Piltonen T, Suturina L, et al. Tolerability and safety of the estetrol/drospirenone combined oral contraceptive: Pooled analysis of two multicenter, open-label phase 3 trials. Contraception. 2022 Dec;116:44-50. doi: 10.1016/j.contraception.2022.10.004. Epub 2022 Oct 17. PMID: 36257374.
7. Kaunitz AM, Achilles SL, Zatik J, Weyers S, Piltonen T, Suturina L, et al. Pooled analysis of two phase 3 trials evaluating the effects of a novel combined oral contraceptive containing estetrol/drospirenone on bleeding patterns in healthy women. Contraception. 2022 Dec;116:29-36. doi: 10.1016/j.contraception.2022.07.010. Epub 2022 Aug 1. PMID: 35921872.
8. Jensen JT, Kaunitz AM, Achilles SL, Zatik J, Weyers S, Piltonen T, Suturina L, et al. Pooled efficacy results of estetrol/drospirenone combined oral contraception phase 3 trials. Contraception. 2022 Dec;116:37-43. doi: 10.1016/j.contraception.2022.07.009. Epub 2022 Jul 31. PMID: 35921870.
9. Suturina LV, Sharifulin EM, Sharifulin MA, et al. The Leydig Steroid Cell Tumor in a Postmenopausal Woman with Clinical and Biochemical Hyperandrogenism: A Case Report. Metabolites. 2022 Jul 4;12(7):620. doi: 10.3390/metabo12070620. PMID: 35888744; PMCID: PMC9320079.
10. Adamyan LV, Andreeva EN, Absatarova YS, Grigoryan OR, Dedov II, Melnichenko GA, Suturina LV, et al. [Clinical guidelines «Polycystic Ovary Syndrome»]. Probl Endokrinol (Mosk). 2022 Feb 6;68(2):112-127. Russian. doi: 10.14341/probl12874. PMID: 35488762; PMCID: PMC9764272.